$2.3 Billion is the total value of Broadfin Capital, LLC's 150 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 31.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON PHARMA PLC | $229,906,000 | +267.9% | 17,835,950 | +250.5% | 10.00% | +52.5% |
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $176,548,000 | +146.5% | 10,306,380 | +105.9% | 7.68% | +2.2% |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $135,342,000 | +191.3% | 17,902,338 | +100.0% | 5.88% | +20.8% |
| EBS | Buy | EMERGENT BIOSOLUTIONS INC | $112,554,000 | +153.9% | 4,133,438 | +98.7% | 4.89% | +5.3% |
| AEGR | Buy | AEGERION PHARMACEUTICALS INC | $106,746,000 | +217.7% | 5,097,726 | +406.4% | 4.64% | +31.7% |
| ANGO | Buy | ANGIODYNAMICS INC | $101,540,000 | +148.8% | 5,341,406 | +79.5% | 4.41% | +3.1% |
| 5100PS | Buy | VOLCANO CORPORATION | $89,216,000 | +742.9% | 4,989,708 | +401.6% | 3.88% | +249.5% |
| RTRX | Buy | RETROPHIN INC | $65,088,000 | +184.4% | 5,317,708 | +107.8% | 2.83% | +18.0% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $57,610,000 | +65.9% | 4,792,798 | +135.8% | 2.50% | -31.2% |
| PTX | Buy | PERNIX THERAPEUTICS HLDGS IN | $57,280,000 | +113.1% | 6,100,000 | +74.3% | 2.49% | -11.6% |
| HRTX | Buy | HERON THERAPEUTICS INC | $56,500,000 | +141.5% | 5,616,346 | +100.0% | 2.46% | +0.1% |
| DEPO | Buy | DEPOMED INC | $55,216,000 | +57.1% | 3,427,404 | +48.1% | 2.40% | -34.8% |
| AMPH | Buy | AMPHASTAR PHARMACEUTICALS IN | $49,408,000 | +114.4% | 4,255,708 | +115.2% | 2.15% | -11.1% |
| AMAG | Sell | AMAG PHARMACEUTICALS INC | $48,888,000 | +1.4% | 1,147,060 | -24.1% | 2.12% | -58.0% |
| PETX | Buy | ARATANA THERAPEUTICS INC | $44,888,000 | +210.0% | 2,518,942 | +74.6% | 1.95% | +28.6% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $41,378,000 | +288.9% | 2,242,740 | +102.6% | 1.80% | +61.3% |
| KND | Buy | KINDRED HEALTHCARE INC | $40,370,000 | +320.1% | 2,220,600 | +348.3% | 1.76% | +74.3% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $38,598,000 | +231.7% | 17,003,500 | +183.5% | 1.68% | +37.5% |
| DSCI | Buy | DERMA SCIENCES INC | $34,576,000 | +127.5% | 3,713,754 | +103.6% | 1.50% | -5.6% |
| ATRC | Buy | ATRICURE INC | $32,970,000 | +141.9% | 1,651,804 | +78.4% | 1.43% | +0.3% |
| ANAC | Buy | ANACOR PHARMACEUTICALS INC | $32,528,000 | +70.2% | 1,008,640 | +29.2% | 1.41% | -29.4% |
| THOR | Buy | THORATEC CORP | $32,460,000 | +142.9% | 1,000,000 | +100.0% | 1.41% | +0.7% |
| UAM | Buy | UNIVERSAL AMERN CORP NEW | $32,212,000 | +113.1% | 3,471,106 | +84.6% | 1.40% | -11.7% |
| IDRA | Buy | IDERA PHARMACEUTICALS INC | $31,096,000 | +285.1% | 7,051,400 | +100.0% | 1.35% | +59.6% |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $25,830,000 | – | 1,532,020 | +100.0% | 1.12% | – |
| ATRS | Buy | ANTARES PHARMA INC | $24,158,000 | +256.8% | 9,400,000 | +154.1% | 1.05% | +47.9% |
| SLXP | New | SALIX PHARMACEUTICALS INC | $22,988,000 | – | 200,000 | +100.0% | 1.00% | – |
| EBIO | Buy | ELEVEN BIOTHERAPEUTICS INC | $22,966,000 | +140.4% | 1,075,515 | +25.4% | 1.00% | -0.4% |
| CNMD | Buy | CONMED CORP | $22,480,000 | +306.8% | 500,000 | +233.3% | 0.98% | +68.7% |
| LGND | New | LIGAND PHARMACEUTICALS INC | $21,178,000 | – | 398,000 | +100.0% | 0.92% | – |
| CORI | Buy | CORIUM INTL INC | $21,188,000 | +146.5% | 3,473,472 | +148.1% | 0.92% | +2.2% |
| ELOS | Buy | SYNERON MEDICAL LTD | $18,758,000 | +86.2% | 2,010,442 | +100.0% | 0.82% | -22.7% |
| DSCO | Buy | DISCOVERY LABORATORIES INC N | $18,714,000 | +26.1% | 16,132,000 | +100.0% | 0.81% | -47.7% |
| IG | Buy | IGI LABS INC | $17,156,000 | +62.2% | 1,949,620 | +71.8% | 0.75% | -32.7% |
| ZGNX | Buy | ZOGENIX INC | $17,092,000 | +163.6% | 12,475,290 | +121.3% | 0.74% | +9.3% |
| TRVN | Buy | TREVENA INC | $16,854,000 | +337.5% | 2,818,306 | +369.7% | 0.73% | +81.4% |
| XNCR | Buy | XENCOR INC | $16,710,000 | +138.1% | 1,041,762 | +38.2% | 0.73% | -1.4% |
| FLXN | Buy | FLEXION THERAPEUTICS INC | $16,686,000 | +328.6% | 826,408 | +287.6% | 0.72% | +77.7% |
| PRTK | New | PARATEK PHARMACEUTICALS INC | $16,054,000 | – | 520,566 | +100.0% | 0.70% | – |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $15,202,000 | +32.6% | 836,612 | -2.1% | 0.66% | -45.0% |
| TENX | Buy | TENAX THERAPEUTICS INC | $15,120,000 | +95.4% | 3,937,262 | +100.0% | 0.66% | -19.0% |
| CPRX | Buy | CATALYST PHARM PARTNERS INC | $14,256,000 | +206.7% | 4,800,000 | +242.9% | 0.62% | +27.3% |
| CEMP | Sell | CEMPRA INC | $13,384,000 | +27.9% | 569,250 | -40.4% | 0.58% | -47.0% |
| ALQA | Buy | ALLIQUA INC | $12,412,000 | +107.0% | 2,341,820 | +51.5% | 0.54% | -14.1% |
| CRDC | Buy | CARDICA INC | $12,424,000 | +30.8% | 17,749,984 | +100.0% | 0.54% | -45.8% |
| BOTA | Buy | BIOTA PHARMACEUTIALS INC | $11,700,000 | +81.4% | 5,223,422 | +100.0% | 0.51% | -24.7% |
| DPRX | Buy | DIPEXIUM PHARMACEUTICALS INC | $10,816,000 | +128.9% | 950,000 | +100.0% | 0.47% | -5.1% |
| ARAY | Buy | ACCURAY INC | $10,570,000 | +191.2% | 1,400,000 | +180.0% | 0.46% | +20.7% |
| ASPX | New | AUSPEX PHARMACEUTICALS INC | $10,496,000 | – | 200,000 | +100.0% | 0.46% | – |
| MDGN | New | MEDGENICS INC | $10,374,000 | – | 2,050,000 | +100.0% | 0.45% | – |
| NVDQ | Buy | NOVADAQ TECHNOLOGIES INC | $10,352,000 | +318.3% | 622,806 | +219.4% | 0.45% | +73.7% |
| IRMD | Buy | IRADIMED CORP | $9,310,000 | +223.3% | 721,768 | +75.7% | 0.40% | +34.1% |
| QLTI | Buy | QLT INC | $9,188,000 | +77.4% | 2,291,054 | +100.0% | 0.40% | -26.5% |
| RXDX | Buy | IGNYTA INC | $8,792,000 | +70.0% | 866,700 | +285.2% | 0.38% | -29.5% |
| ADMA | New | ADMA BIOLOGICS INC | $8,694,000 | – | 778,386 | +100.0% | 0.38% | – |
| REPH | Buy | RECRO PHARMA INC | $8,086,000 | +133.0% | 2,827,066 | +141.2% | 0.35% | -3.3% |
| AQXP | Buy | AQUINOX PHARMACEUTICALS INC | $7,976,000 | +134.6% | 1,063,536 | +108.3% | 0.35% | -2.5% |
| HZNP | Buy | HORIZON PHARMA PLCcall | $7,734,000 | +1618.7% | 600,000 | +29900.0% | 0.34% | +614.9% |
| ONTY | Buy | ONCOTHYREON INC | $7,600,000 | +163.9% | 4,000,000 | +166.7% | 0.33% | +9.3% |
| AFAM | Buy | ALMOST FAMILY INC | $7,460,000 | +22.5% | 257,682 | +14.9% | 0.32% | -49.3% |
| HTWR | New | HEARTWARE INTL INC | $7,344,000 | – | 100,000 | +100.0% | 0.32% | – |
| DRRX | Buy | DURECT CORP | $6,952,000 | +7.4% | 8,808,990 | +100.0% | 0.30% | -55.5% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $6,844,000 | +111.6% | 369,512 | +100.0% | 0.30% | -12.1% |
| RDHL | Buy | REDHILL BIOPHARMA LTDsponsored ads | $6,706,000 | +93.5% | 503,018 | +91.1% | 0.29% | -19.6% |
| CASM | Buy | CAS MED SYS INC | $6,330,000 | +70.1% | 3,836,592 | +100.0% | 0.28% | -29.5% |
| AEGR | New | AEGERION PHARMACEUTICALS INCcall | $6,282,000 | – | 300,000 | +100.0% | 0.27% | – |
| TNXP | Buy | TONIX PHARMACEUTICALS HLDG C | $5,860,000 | +209.6% | 1,003,278 | +263.0% | 0.26% | +28.8% |
| ANTH | Buy | ANTHERA PHARMACEUTICALS INC | $5,636,000 | +125.5% | 3,567,624 | +174.1% | 0.24% | -6.5% |
| MASI | New | MASIMO CORP | $5,158,000 | – | 195,800 | +100.0% | 0.22% | – |
| CLTX | Buy | CELSUS THERAPEUTICS PLCsponsored adr ne | $4,520,000 | +57.4% | 941,754 | +100.0% | 0.20% | -34.6% |
| AMRN | New | AMARIN CORP PLCspons adr new | $4,376,000 | – | 4,467,492 | +100.0% | 0.19% | – |
| RXII | Buy | RXI PHARMACEUTICALS CORP NEW | $3,604,000 | +60.0% | 2,252,964 | +100.0% | 0.16% | -33.5% |
| BIOD | Buy | BIODEL INC | $3,538,000 | +59.3% | 2,660,068 | +100.0% | 0.15% | -33.9% |
| PGNX | New | PROGENICS PHARMACEUTICALS INcall | $3,024,000 | – | 400,000 | +100.0% | 0.13% | – |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $328,000 | – | 31,116 | +100.0% | 0.01% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INCcall | $0 | – | -1,500 | -100.0% | -0.05% | – |
| DRAD | Exit | DIGIRAD CORP | $0 | – | -332,480 | -100.0% | -0.14% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -800,000 | -100.0% | -0.38% | – |
| LBMH | Exit | LIBERATOR MEDICAL HLDGS INC | $0 | – | -1,150,837 | -100.0% | -0.38% | – |
| RAD | Exit | RITE AID CORP | $0 | – | -1,675,000 | -100.0% | -0.85% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -303,000 | -100.0% | -1.02% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -7,660,100 | -100.0% | -1.15% | – |
| NTUS | Exit | NATUS MEDICAL INC DEL | $0 | – | -464,915 | -100.0% | -1.44% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -658,929 | -100.0% | -1.64% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -959,247 | -100.0% | -2.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIODELIVERY SCIENCES INTL IN | 27 | Q4 2019 | 4.8% |
| HERON THERAPEUTICS INC | 24 | Q4 2019 | 9.0% |
| LA JOLLA PHARMACEUTICAL CO | 24 | Q4 2019 | 7.7% |
| RECRO PHARMA INC | 24 | Q4 2019 | 4.1% |
| ANTARES PHARMA INC | 24 | Q3 2019 | 3.4% |
| RETROPHIN INC | 23 | Q3 2019 | 7.0% |
| ARATANA THERAPEUTICS INC | 22 | Q2 2019 | 8.1% |
| MIRATI THERAPEUTICS INC | 22 | Q1 2019 | 7.9% |
| CATALYST PHARM PARTNERS INC | 22 | Q3 2019 | 6.2% |
| ANGIODYNAMICS INC | 21 | Q3 2018 | 6.6% |
View Broadfin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eiger BioPharmaceuticals, Inc.Sold out | January 04, 2021 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL COSold out | January 04, 2021 | 0 | 0.0% |
| STRATA Skin Sciences, Inc. | June 23, 2020 | 1,529,392 | 4.5% |
| Teligent, Inc.Sold out | February 25, 2020 | 0 | 0.0% |
| Neos Therapeutics, Inc.Sold out | February 14, 2020 | 0 | 0.0% |
| Aclaris Therapeutics, Inc. | February 13, 2020 | 1,888,039 | 4.6% |
| Adamas Pharmaceuticals IncSold out | February 13, 2020 | 0 | 0.0% |
| ADMA BIOLOGICS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
| AVADEL PHARMACEUTICALS PLC | February 13, 2020 | 1,029,012 | 2.8% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 13, 2020 | 0 | 0.0% |
View Broadfin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-03-22 |
| 4 | 2022-02-15 |
| 4 | 2022-01-31 |
| 4 | 2021-11-22 |
| 4 | 2021-11-15 |
| 4 | 2021-11-09 |
| 4 | 2021-08-10 |
| 4 | 2021-05-13 |
| SC 13G/A | 2021-01-04 |
| SC 13G/A | 2021-01-04 |
View Broadfin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.